Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

The US Food and Drug Administration (FDA) has approved INBRIJA – an inhalable drug created by US biotech company Acorda Therapeutics – for intermittent treatment.

INBRIJA is designed to treat Parkinson’s symptoms that occur between oral doses of medication, which are known as ‘off’ episodes. The drug has been approved by the FDA and – after a clinical study involving 900 people with Parkinson’s – is expected to be available in 2019.

Todd Sherer, CEO of The Michael J Fox Foundation, who funded early trials of the powder, said: “Despite being on treatment, patients may experience OFF periods as Parkinson’s progresses, which can be disruptive.

“We knew we had to help address this unmet need, and this approval is a significant step forward for the community as it provides a new option to manage these gaps in symptom control.”

To read more on this topic click here.

For more information on Parkinson’s medication please visit the EPDA website.

Memory loss could be an indication of Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Global update

#UNITED for Parkinson’s: the race is on

“More than just an awareness campaign”

Sir Billy Connolly: stop calling Parkinson’s ‘incurable’

The Scottish comedian calls for more positive Parkinson's language

Trouble sleeping? Listen to a free podcast about sleep and Parkinson’s

Discussing a common nocturnal nemesis for people with Parkinson's

Has Covid-19 impacted access to Parkinson’s medication?

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease. The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors. The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication. “Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Researchers at the Federal University of Rio Grande do Sul in Brazil compared participants in a 12-week programme, inspired by samba and forró dances, with those in a walking exercise programme to measure improvement in their functional mobility and gait. The 18 participants had an average age of 68.6 and had all been diagnosed with Parkinson’s over a year ago. The results, published in journal BMC Neurology, found that both groups showed significant improvements in mobility and balance tests. Participants in the dance group showed increases in stride frequency at a self-chosen test speed and a reduced swing time (the amount of time the foot is off the floor) at a fast speed. The results indicated that dance was as “effective as walking in improving functional mobility”. The researchers wrote: “It is essential to find different activities that can offer benefits to individuals… so that they can engage in the…

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

Parkinson’s Life’s #WomenAndParkinsons campaign – a series highlighting the unique experiences of the estimated three million women worldwide who live with the condition – has been shortlisted in the UK Content Awards 2020 in the ‘Not-for-Profit / Charity Content Campaign of the Year’ category. Since its launch in 2019 the #WomenAndParkinsons campaign has covered topics including: the impact of menstruation on medication; the difficulties surrounding pregnancy, childbirth and breastfeeding with Parkinson’s; the interaction between menopause, sex and Parkinson’s; how coronavirus is impacting the lives of women with the condition; and what’s behind the lack of focus on gender. Parkinson’s Life editor Simge Eva Dogan, said: “Our campaign has centered on voices that were previously unheard and started much-needed discussions about the specific needs and experiences of women who are living with Parkinson’s. Being recognised by this award will help us to build on the success of the campaign so far and continue…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

#UNITED for Parkinson’s: the race is on

Global update

Sir Billy Connolly: stop calling Parkinson’s ‘incurable’

Resources & Tools

Trouble sleeping? Listen to a free podcast about sleep and Parkinson’s

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

{title}

Subscribe

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

#UNITED for Parkinson’s: the race is on

Global update

Sir Billy Connolly: stop calling Parkinson’s ‘incurable’

Resources & Tools

Trouble sleeping? Listen to a free podcast about sleep and Parkinson’s

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

{title}

Subscribe

Sign in